LFVN
$4.74-0.41 (-8.06%)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It offer...
Recent News
How The LifeVantage (LFVN) Investment Story Is Resetting After Analyst Valuation Changes
LifeVantage’s analyst price target has been reset around a model fair value of US$8.00, with the latest work keeping that headline number steady even as several underlying assumptions shift slightly. Analysts characterise this move as a reset of expectations rather than a rewrite of the story, tying the unchanged fair value to refreshed views on discount rate, revenue trajectory, profit margin and future P/E. As you read on, you will see how this updated target feeds into the ongoing bull and...
Promising Penny Stocks To Consider In February 2026
As February begins, U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. While larger market trends capture headlines, investors often overlook smaller opportunities such as penny stocks, which despite their vintage name, continue to offer potential for significant returns when backed by solid financials. This article explores three promising penny stocks that combine balance sheet strength with...
Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks
As February begins, the U.S. stock market is showing strength, with major indexes like the Dow Jones and S&P 500 posting significant gains. In this context of rising indices, investors often look for opportunities that may offer growth potential at a lower entry cost. Penny stocks, though considered a niche investment area today, still hold promise by offering access to smaller or newer companies that can potentially deliver strong returns when backed by solid financials. Let's explore...
How The Narrative Around LifeVantage (LFVN) Is Shifting After The Price Target Reset
The recent cut in LifeVantage’s fair value target from $14.50 to $8.00, roughly a 45% reset in implied valuation, marks a clear shift in how analysts are weighing execution risk against potential upside. Behind that move, revenue expectations have swung from about 4.02% growth to a 7.41% decline, with only a marginal tweak to the discount rate from 7.63% to 7.62%. This shows that the bigger rethink sits in the outlook for the top line rather than the core risk profile. As this new narrative...
Spotlight On February 2026's Promising Penny Stocks
As February 2026 begins, major U.S. stock indexes have shown robust performance, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing record highs. This market momentum sets a promising backdrop for exploring investment opportunities in various sectors. Despite its somewhat outdated terminology, the concept of penny stocks remains significant as these smaller or newer companies can offer a blend of affordability and growth potential when backed by strong financials...